Increasingly, medical science is discovering that inflammation within the body can lead to a range of life-threatening degenerative diseases such as coronary heart disease, diabetes, macular degeneration, and cognitive decline. By measuring your body’s level of inflammation through regular C-reactive protein testing, you can devise a strategy of diet, exercise, and supplementation to halt many of these conditions.
C-reactive protein (CRP) is a sensitive marker of systemic inflammation that has emerged as a powerful predictor of coronary heart disease and other diseases of the cardiovascular system.32 The highly sensitive cardiac CRP test measures C-reactive protein in the blood at very early stages of vascular disease, allowing for appropriate intervention with diet, supplements, or anti-inflammatory therapy. The cardiac CRP test detects much smaller levels of inflammation than the basic CRP test, so is therefore able to identify at-risk patients earlier, even among apparently healthy persons.
A review of epidemiological data found that high-sensitivity cardiac CRP was able to predict risk of incident myocardial infarction, stroke, peripheral arterial disease, and sudden cardiac death among healthy individuals with no history of cardiovascular disease, as well as predict recurrent events and death in patients with acute or stable coronary syndromes. This inflammatory marker provided prognostic information that was independent of other measures of risk such as cholesterol level, metabolic syndrome, and high blood pressure. Investigators concluded that greater levels of cardiac CRP are associated with higher cardiovascular risk.
Iron deficiency anemia: Iron-deficiency anemia is a blood condition characterized by low levels of iron in the body which leads to a reduction in the number of red blood cells.
Raynaud's phenomenon is a condition in which there are spasms, constriction and narrowing of the capillaries of the fingers and toes. Capillaries are the smallest arteries that supply vital oxygen and nutrients to cells and tissues.
A steady supply of oxygen and nutrients are critical to the health of the cells and tissues of the fingers and toes. Narrowing of the blood vessels that occurs in Raynaud's phenomenon interferes with this supply. This is called ischemia. In ischemia, cells are unable to reproduce normally, recover effectively from injury, and fight infection. This leads to the symptoms and complications of Raynaud's phenomenon. These include color changes, cold fingers and toes, and the development of sores or lesions that do not heal. If Raynaud's phenomenon is left untreated, gangrene (tissue death) can occur. Less commonly, Raynaud's phenomenon can also cause symptoms and complications in the nose, lips, and earlobes. For more information on symptoms and complications, refer to symptoms of Raynaud's phenomenon.
First stage test FBE, ESR, U&E, TFT, TFT calcium, Vitamin B12
Second stage test Red cell folate, Syphilis serology, blood lead
B12 and folate are primarily ordered to help diagnose the cause of macrocytic anemia. They are ordered as follow-up tests when large RBCs and a decreased hemoglobin concentration are found during a CBC test. Folate, B12, and an assortment of other tests may be ordered to help evaluate the general health and nutritional status of a patient with signs of significant malnutrition or malabsorption. This may include people with alcoholism and those with conditions associated with malabsorption such as celiac disease, Crohn’s disease, and cystic fibrosis. B12 and folate may also be ordered to help diagnose the cause of mental or behavioral changes, especially in the elderly.
B12 may be ordered with folate, by itself, or with other screening laboratory tests – such as a CMP (comprehensive metabolic panel) – to help diagnose the cause of neuropathy.
In patients with known B12 and folate deficiencies, these tests may be ordered occasionally to help monitor the effectiveness of treatment. This is especially true in patients who cannot absorb B12 and/or folate and must have lifelong treatment.
E/LFT is an abbreviation for a combination of tests used to evaluate kidney and liver function. These include both electrolytes and liver function tests
Anti-CCP stands for anti-cyclic citrullinated peptide antibody. This is an antibody produced by the body in the presence of the medical condition rheumatoid arthritis. This antibody is tested along for the presence of another antibody rheumatoid factor (RF) for confirmation that the person has rheumatoid arthritis. It is a fairly new test used in the diagnostic testing for rheumatoid arthritis.
The anti-CCP test results is one way for the physician to determine if a person has rheumatoid arthritis. This is one method of confirming this autoimmune disease from other autoimmune diseases, as someone may have more than one at a time.
This test is completed on blood taken from the person’s arm using a hypodermic needle and torniquet. The sample is then sent to be analyzed by the laboratory. Previous experiments have shown that anti-CCP test levels can also indicate disease before other test markers have become positive. Thus it can also be used as an indicator that the person may develop rheumatoid athritis.
Another reason why this test might be ordered is to measure the effectiveness of the treatment the physician has administered. If the patient is responding to treatment, then the level of this antibody should be low.
I am drained... exhausted to be more accurate..but very happy!
Remmember Richard I am not a doctor nor pretend to be one at all ( and they know a lot , but I mean a lot more than I), this may not be perfect... but believe me when I say I gave it my best.
Take good care of yourself.
One last thing you have to promise me... you will never, ever harm yourself again... OK